Skip to main content
SpringerLink
Log in

Clinical Gene Therapy for Brain Tumors. Liposomal Delivery of Anticancer Molecule to Glioma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Liposomes are one of the most promising delivery systems for genes, proteins, and other biological molecules and they are expected to become a new therapeutic tool for the treatment of brain tumors, especially malignant gliomas. Until now, transfer of anticancer molecules using liposomes has been studied by a lot of investigators and it has been found to induce regression of experimental gliomas, resulting in establishing some original and effective therapies. Gene therapy using cationic liposomes is also one of them. Here we introduce the advanced medicine for brain tumors using liposomes containing some anticancer molecules (for example, gene, antibody, antisense, or magnetite), based on our basic and clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bethune CR, Geyer RJ, Spence AM, Ho RJ: Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats. Cancer Res 61: 3669-3674, 2001

    Google Scholar 

  2. Kito A, Yoshida J, Kageyama N, Kojima N, Yagi K: Liposomes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma. J Neurosurg 71: 382-387, 1989

    Google Scholar 

  3. Zhang Y, Jeong Lee H, Boado RJ, Pardridge WM:Receptormediated delivery of an antisense gene to human brain cancer cells. J Gene Med 4: 183-184, 2002

    Google Scholar 

  4. Koukourakis MI, Koukourakis S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, Karkavitsas N: High intratumoral accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastoma and in metastaic brain tumours. Br J Cancer 86: 659-661, 2002

    Google Scholar 

  5. Cerletti A, Drewe J, Fricker G, Eberie AN, Huwyler J: Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target 8: 435-446, 2000

    Google Scholar 

  6. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JR, Ringold GM, Danielson M: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413-7414, 1987

    Google Scholar 

  7. Felgner RL, Ringold GM: Cationic liposome-mediated transfection. Nature 337: 387-388, 1989

    Google Scholar 

  8. Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, Koshizaka T, Yagi K: Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 50: 7826-7829, 1990

    Google Scholar 

  9. Mizuno M, Yoshida J, Sugita K, Yagi K: Growth inhibition of glioma cells of different cell lines by human interferon-? produced in the cells transfected with its gene by means of liposomes. J Clin Biochem Nutr 9: 73-77, 1990

    Google Scholar 

  10. Yoshida J, Mizuno M, Yagi K: Secretion of human ?-interferon into the cystic fliud of glioma transfected with the interferon gene. J Clin Biochem Nutr 11: 123-128, 1991

    Google Scholar 

  11. Yoshida J, Mizuno M, Yagi K: Antitumor effect of endogenous human ?-interferon on malignant glioma and augmentation of the effect by tumor necrosis factor-±. J Clin Biochem Nutr 12: 153-160, 1992

    Google Scholar 

  12. Mizuno M, Yoshida J, Oyama H, Sugita K: Growth inhibition of glioma cells by liposome-mediated cell tansfection with tumor necrosis factor-α gene. Its enhancement by prior ?-interferon treatment. Neurologia medico-chirurgica (Tokyo) 32: 873-876, 1992

    Google Scholar 

  13. Yoshida J, Mizuno M, Yagi K: Cytotoxicity of human β-interferon produced human glioma cells transfected with its gene by means of liposomes. Biochemistry International 28: 1055-1061, 1992

    Google Scholar 

  14. Yagi K, Noda H, Kurono M, Ohishi N: Efficient gene transfer with less than cytotoxicity by means of cationic multilamellar liposomes. Biochem Biophys Res Commun 196: 1042-1048, 1993

    Google Scholar 

  15. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756, 1989

    Google Scholar 

  16. Schulze-Osthoff K, Krammer PH, Droge W: Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13: 4587-4596, 1994

    Google Scholar 

  17. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993

    Google Scholar 

  18. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ, Fontana A: Fas gene transfer for human malignant glioma. Cancer Res 55: 2936-2944, 1995

    Google Scholar 

  19. Ohta S, Mizuno M, Takaoka T, Yoshida J: Augmentation of anti-Fas antibody-mediated apoptosis on human glioma cells by liposomes associated with the antibody. J Neuro-Oncol 35: 7-11, 1997

    Google Scholar 

  20. Sugawa N, Ueda S, Nakagawa Y, Nishino H, Nosaka K, Iwashima A, Kurimoto M: An antisense EGFR oligonucleotide enveloped in Lipofectin induces growth inhibition in human malignant gliomas in vitro. J Neuro-Oncology 39: 237-244, 1998

    Google Scholar 

  21. Wiesenhofer B, Weis C, Humpel C: Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments. Antisense Nucleic Acid Drug Dev 10: 311-321, 2000

    Google Scholar 

  22. Shinkai M, Ueda K, Ohtsu S, Honda H, Kohri K, Kobayashi T: Effect of fuctional magnetic particles on radiofrequency capacitive heating: an in vivo study. Jpn J Cancer Res 93: 103-108, 2002

    Google Scholar 

  23. Ito A, Shinkai M, Honda H, Kobayashi T: Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther 9: 649-654, 2001

    Google Scholar 

  24. Zerrouqi A, Rixe O, Ghoumari AM, Yarovoi SV, Mouawad R, Khayat D, Soubrane C: Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir. Cancer Gene Ther 3: 385-392, 1996

    Google Scholar 

  25. Voges J, Weber F, Reszka R, Sturm V, Jacobs A, Heiss WD, Wiestler O, Kapp JF: Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme. Hum Gene Ther 13: 675-685, 2002

    Google Scholar 

  26. Von Eckardstein KL, Patt S, Zhu J, Cervos-Navarro J, Reszka R: Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors. Histol Histopathol 16: 735-744, 2001

    Google Scholar 

  27. Dewey RA, Morrissey G, Cowsill CM, Stone D, Bolognani F, Dodd NJ, Southgate TD, Klatzmann D, Lassmann H, Castro MG, Lowenstein PR: Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implication for clinical trials. Nat Med 5: 1256-1263, 1999

    Google Scholar 

  28. Mabuchi E, Shimizu K, Miyao Y, Kaneda Y, Kishima H, Tamura M, Ikenaka K, Hayakawa T: Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma. Gene Ther 4: 768-772, 1997.

    Google Scholar 

  29. Mizuno M, Yoshida J: Effect of human interferon-b gene transfer upon human glioma transplanted into nude mouse brain involves induced natural killer cells. Cancer Immunol Immunother 47: 227-232, 1998

    Google Scholar 

  30. Natsume A, Mizuno M, Ryuke Y, Yoshida J: Antitumor effect and cellular immunity activation by murine interferon-b gene transfer against intracerebral glioma in mouse. Gene Therapy 6: 1626-1633, 1999

    Google Scholar 

  31. Natsume A, Tsujimura K, Mizuno M, Takahashi T, Yoshida J: IFN-b gene therapy induces systemic antitumor immunity against malignant glioma. J Neuro-Oncology 47: 117-124, 2000

    Google Scholar 

  32. Berns KI, Bohensky RA: Adeno-associated virus: an update. Adv Virus Res 32: 243-306, 1987

    Google Scholar 

  33. Srivastava A, Lusby EW, Berns KI: Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 45: 555-564, 1983

    Google Scholar 

  34. Atchinson RW, Castro BC, Hammond WM: Adenoassociated defective particles. Science 149: 754-756, 1965

    Google Scholar 

  35. Buller RM, Janik JE, Sebring ED, Rose JA: Herpes simplex virus types 1 and 2 completely help adeno-associated virus replication. J Virol 40: 241-247, 1981

    Google Scholar 

  36. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA: Targeted integration of adenoassociated virus (AAV) into human chromosome 19.EMBO J 10: 3941-3950, 1991

    Google Scholar 

  37. Linden RM, Ward P, Giraud C, Winocour E, Berns KI: Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 93: 11288-11294, 1996

    Google Scholar 

  38. Mizuno M, Yoshida J: Improvement of transduction effi-ciency of recombinant adeno-associated virus vector by entrapment in multilamellar liposomes. Jpn J Cancer Res 89: 352-354, 1998

    Google Scholar 

  39. Natsume A, Mizuno M, Ryuke Y, Yoshida J: Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity. Jpn J Cancer Res 91: 363-367, 2000

    Google Scholar 

  40. Mizuno M, Ryuke Y, Yoshida J: Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse subcutaneous glioma model. Cancer Gene Ther 9: 825-829, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Jun Yoshida

  2. Department of Molecular Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Masaaki Mizuno

Authors
  1. Jun Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaaki Mizuno
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, J., Mizuno, M. Clinical Gene Therapy for Brain Tumors. Liposomal Delivery of Anticancer Molecule to Glioma. J Neurooncol 65, 261–267 (2003). https://doi.org/10.1023/B:NEON.0000003655.03671.fa

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:NEON.0000003655.03671.fa

Search

Navigation